ScreenerHero
AMGNAmgen Inc.
NAS · US · Healthcare · Drug Manufacturers - General · amgen.com
344.67USD-0.01%Mkt Cap: 186.05B $P/E: 23.97

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthriti…

Industry Peers

Drug Manufacturers - General
Screen all
vs Drug Manufacturers - General
P/E
Pricier
P/B
Pricier
Div Yield
Avg
1M Perf
Lower
LLY
Eli Lilly and Company
$982.77BUSDP/E 39.2
+832.4% 1M
JNJ
Johnson & Johnson
$556.77BUSDP/E 26.8
+85.9% 1M
ABBV
AbbVie Inc.
$406.29BUSDP/E 112.7
+834.2% 1M
RO
Roche Holding AG
$294.39BUSDP/E 20.2
-316.6% 1M
NOVNEE
Novartis AG
$267.10BUSDP/E 21.4
+82.1% 1M
MRK
Merck & Co., Inc.
$285.22BUSDP/E 32.5
+217.7% 1M
NOVN
Novartis AG
$261.94BUSDP/E 21.6
+87.2% 1M
AZN
AstraZeneca PLC
$251.74BUSDP/E 26.7
-398.9% 1M
AZN
AstraZeneca PLC
$224.03BUSDP/E 26.4
-511.2% 1M
NOVO-B
Novo Nordisk A/S
$193.45BUSDP/E 10.9
+400.5% 1M
GILD
Gilead Sciences, Inc.
$155.03BUSDP/E 17.0
-445.3% 1M
PFE
Pfizer Inc.
$142.94BUSDP/E 19.1
-275.3% 1M
BMY
Bristol-Myers Squibb Company
$111.70BUSDP/E 15.3
-656.0% 1M
SAN
Sanofi
$94.31BUSDP/E 18.3
-567.1% 1M
GSK
GSK plc
$83.84BUSDP/E 13.6
+52.2% 1M
BAYN
Bayer Aktiengesellschaft
$40.77BUSD
-187.6% 1M
MRV
Marvell Technology, Inc.
$32.03BUSDP/E 12.2
+5682.2% 1M
BIIB
Biogen Inc.
$29.48BUSDP/E 21.5
+634.2% 1M
REC
Recordati Industria Chimica e Farmaceutica S.p.A.
$11.28BUSDP/E 22.6
-58.5% 1M
ORNBV
Orion Oyj
$10.49BUSDP/E 18.2
-372.4% 1M
ORNAV
Orion Oyj
$10.49BUSDP/E 18.2
-338.5% 1M
GRF
Grifols, S.A.
$6.69BUSDP/E 14.8
-475.9% 1M
OGN
Organon & Co.
$3.52BUSDP/E 14.4
-44.6% 1M
VIRP
Virbac SA
$3.08BUSDP/E 18.8
-583.3% 1M
SCLX
Scilex Holding Company
$48.32MUSD
+1431.0% 1M
MIRA
MIRA Pharmaceuticals, Inc.
$39.98MUSD
-170.4% 1M
ELXR
Elixxer Ltd.
$9.51MUSD
+1666.7% 1M
ROSE
DocMorris AG
—
+1809.0% 1M
CELG-RI
Bristol-Myers Squibb Company Ce
—
FLXN
Horizon Flexible Income ETF
—P/E 27.4
+30.1% 1M
PHOO
Photocure ASA
—
FR0000140022
SANOFITP29OCT49
—
Indicators:|

Key Statistics

Company
Market Cap186.05B $
Enterprise Value227.49B $
Revenue (TTM)37.22B $
Gross Profit24.71B $
Net Income (TTM)7.71B $
Revenue/Share69.12 USD
Last Price344.67 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees31.5K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS0311621009
Valuation
P/E (Trailing)23.97
P/E (Forward)14.38
PEG2.23
EV/EBITDA13.45
EV/Revenue6.11
P/S4.90
P/B19.83
EPS (TTM)14.38
EPS (Forward)23.48
52W Range
267.8362% of range391.29
52W High391.29 USD
52W Low267.83 USD
Profitability
Gross Margin67.25%
Oper. Margin33.80%
EBITDA Margin45.45%
Profit Margin20.98%
ROE89.06%
ROA8.51%
Growth
Revenue Growth5.80%
Earnings Growth4.40%
Cash Flow & Leverage
Operating CF9.96B $
CapEx (TTM)1.86B $
FCF Margin19.98%
FCF Yield4.00%
Net Debt45.29B $
Net Debt/EBITDA2.68
Balance Sheet
Debt/Equity6.31
Current Ratio1.26
Quick Ratio0.85
Book Value/Sh17.03 USD
Cash/Share22.30 USD
Dividends
Fwd Div Rate10.08 USD
Trail. Div Rate9.660 USD
Div. Yield2.99%
5Y Avg Yield3.07%
Payout Ratio67.22%
Ex-Div DateMay 15, 2026
Pay DateJun 5, 2026
Splits
Last Split2:1
Split DateNov 22, 1999
Analyst Consensus
Rating2.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)352.77 USD
Upside (mean)+2.3%
Target Range200.00 USD – 427.00 USD
$200.00+2.3% to mean$427.00
# Analysts30
Ownership
Shares Out.539.71M
Float538.21M
Insiders0.22%
Institutions85.22%
Short Interest
Short Ratio4.4d
Short % Float2.20%
Short % Out.2.20%
Shares Short11.85M
Short (prev mo.)12.97M
Technical
SMA 50340.26 (+1.3%)
SMA 200331.88 (+3.9%)
Beta0.42
S&P 52W Chg24.49%
Avg Vol (30d)2.61M
Avg Vol (10d)3.93M
Technical Indicators
RSI (14)52.3
MACD1.9283
MACD Signal1.9182
MACD Hist.+0.0101
BB Upper356.63 USD
BB Middle341.82 USD
BB Lower327.01 USD
BB Width8.66%
ATR (14)8.961 USD
Vol Ratio (20d)0.97x